Biolife Secures U.S. Patent for Oral Peptide Delivery Technology
Biolife has received a U.S. patent for a novel effervescent oral peptide delivery technology. The approach centers on an effervescent formulation designed to facilitate the oral delivery of peptide-based therapeutics—a notable development given that peptides are typically administered via injection due to their vulnerability to degradation in the